Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:06 AM
Ignite Modification Date:
2025-12-25 @ 2:06 AM
NCT ID:
NCT02471560
Eligibility Criteria:
Key Inclusion Criteria:
* Have a confirmed diagnosis of RRMS and satisfy the therapeutic indication as described in the local label.
* Female subjects of childbearing potential who are not surgically sterile must practice effective contraception according to the summary of product characteristics (SPC) during their participation in the study and be willing and able to continue contraception for 30 days after their last dose of study treatment.
Key Exclusion Criteria:
* Diagnosis of primary progressive, secondary progressive or progressive relapsing MS.
* Antibiotic treatment in the last month prior to study entry.
* Scheduled alteration of diet, including the use of probiotics.
NOTE: Other protocol defined inclusion/exclusion criteria may apply.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT02471560
Study Brief:
Protocol Section:
NCT02471560